SYDNEY, June 12, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced a key leadership appointment in…
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1…
London, UK, June 07, 2025 (GLOBE NEWSWIRE) -- Amid growing global economic uncertainty and ongoing pressure from fiat currency devaluation,…
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been writing a new…
Aviva platform continues development of innovative technology to support advisers.The latest innovation, the Aviva Analytics tool, is now live with selected…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…